Body

Unraveling the genetic mystery of medieval leprosy

Why was there a sudden drop in the incidence of leprosy at the end of the Middle Ages? To answer this question, biologists and archeologists reconstructed the genomes of medieval strains of the pathogen responsible for the disease, which they exhumed from centuries old human graves. Their results, published in the journal Science, shed light on this obscure historical period and introduce new methods for understanding epidemics.

Putting flesh on the bones of ancient fish

This week in the journal Science, Swedish and Australian researchers present the miraculously preserved musculature of 380 million year old fossil fishes, revealed by unique fossils from a locality in north-west Australia. The finds will help scientists to understand how neck muscles and abdominal muscles – "abs" – evolved.

Putting flesh on the bones of ancient fish

Grenoble, 12 June 2013: Swedish, Australian and French researchers present for the first time miraculously preserved musculature of 380 million year old armoured fish discovered in north-west Australia. This research will help scientists to better understand how neck and abdominal muscles evolved during the transition from jawless to jawed vertebrates. The scientific paper describing the discovery is published today in the journal Science.

Study: Context crucial when it comes to mutations in genetic evolution

With mutations, it turns out that context can be everything in determining whether or not they are beneficial to their evolutionary fate.

According to the traditional view among biologists, a central tenet of evolutionary biology has been that the evolutionary fates of new mutations depend on whether their effects are good, bad or inconsequential with respect to reproductive success. Central to this view is that "good" mutations are always good and lead to reproductive success, while "bad" mutations are always bad and will be quickly weeded out of the gene pool.

Monell-led research identifies scent of melanoma

PHILADELPHIA (June 13, 2013) -- According to new research from the Monell Center and collaborating institutions, odors from human skin cells can be used to identify melanoma, the deadliest form of skin cancer. In addition to detecting a unique odor signature associated with melanoma cells, the researchers also demonstrated that a nanotechnology-based sensor could reliably differentiate melanoma cells from normal skin cells. The findings suggest that non-invasive odor analysis may be a valuable technique in the detection and early diagnosis of human melanoma.

Dangerous strains of E. coli may linger longer in water than benign counterparts, study finds

BUFFALO, N.Y. — A toxin dangerous to humans may help E. coli fend off aquatic predators, enabling strains of E. coli that produce the toxin to survive longer in lake water than benign counterparts, a new study finds.

Researchers from the University at Buffalo and Mercyhurst University reported these results online June 7 in the journal Applied and Environmental Microbiology.

Black locust showing promise for biomass potential

URBANA, Ill. – Researchers from the Energy Biosciences Institute at the University of Illinois, evaluating the biomass potential of woody crops, are taking a closer look at the black locust (Robinia pseudoacacia), which showed a higher yield and a faster harvest time than other woody plant species that they evaluated, said U of I associate professor of crop sciences Gary Kling.

Yale researchers unravel genetics of dyslexia and language impairment

A new study of the genetic origins of dyslexia and other learning disabilities could allow for earlier diagnoses and more successful interventions, according to researchers at Yale School of Medicine. Many students now are not diagnosed until high school, at which point treatments are less effective.

Culprit implicated in neurodegenerative diseases also critical for normal cells

The propensity of proteins to stick together in large clumps—termed "protein aggregation"—is the culprit behind a variety of conditions including Huntington's, Alzheimer's, and mad cow diseases. With this notoriety, protein aggregation is considered to be a bad accident of nature that happens when protein structure is mismanaged. But new research published online on June 13th in the Cell Press journal Developmental Cell shows that, when kept in balance, protein aggregation has beneficial functions that allow cells to organize themselves in both time and space.

Mount Sinai researchers succeed in programming blood forming stem cells

(New York, NY – June 13, 2013)--By transferring four genes into mouse fibroblast cells, researchers at the Icahn School of Medicine at Mount Sinai have produced cells that resemble hematopoietic stem cells, which produce millions of new blood cells in the human body every day. These findings provide a platform for future development of patient-specific stem/progenitor cells, and more differentiated blood products, for cell-replacement therapy.

Protein protects against breast cancer recurrence in animal model

PHILADELPHIA - According to the American Cancer Society, nearly 40,000 women in the United States will succumb to breast cancer this year. Most of these women will die not from the primary tumor but rather tumor recurrence – the reappearance of the disease following treatment.

Newly identified markers may predict who will respond to breast cancer prevention therapy

PHILADELPHIA — Genetic variations, known as single nucleotide polymorphisms (SNPs), in or near the genes ZNF423 and CTSO were associated with breast cancer risk among women who underwent prevention therapy with tamoxifen and raloxifene, according to data published in Cancer Discovery, a journal of the American Association for Cancer Research.

Genetic variations may help identify best candidates for preventive breast cancer drugs

ROCHESTER, Minn. -- Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.

"Our findings are important because we identified genetic factors that could eventually be used to select women who should be offered the drugs for prevention," said James Ingle, M.D., an oncologist at Mayo Clinic.

Gene variants may predict who will benefit from breast cancer prevention drugs

In women at high risk for breast cancer, a long-term drug treatment can cut the risk of developing the disease in half. Researchers supported by the National Institutes of Health have now identified two gene variants that may predict which women are most likely to benefit from this therapy—and which should avoid it.

The work represents a major step toward truly individualized breast cancer prevention in women at high risk for the disease based on their age, family history of breast cancer, and personal medical history.

Gene offers an athlete's heart without the exercise

Researchers at Case Western Reserve University have found that a single gene poses a double threat to disease: Not only does it inhibit the growth and spread of breast tumors, but it also makes hearts healthier.

In 2012, medical school researchers discovered the suppressive effects of the gene HEXIM1 on breast cancer in mouse models. Now they have demonstrated that it also enhances the number and density of blood vessels in the heart – a sure sign of cardiac fitness.